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Abstract: In recent years transdermal drug delivery has aroused significant interest as a sustained and non-invasive 
way of administering active substances. The advancements of nanotechnology allowed the development of novel 
pharmaceutical formulations overcoming skin barrier. Furthermore, such nano-system can be combined with 
conventional fabrics to pave the way to a new generation of wearable drug delivery devices: bio-functional 
garments. First the NP were produced by flash nanoprecipitation technique (FNP), the production process was 
optimized to produce particles with suitable size for transdermal applications. The nanoparticles were 
characterized in terms of drug content by UV-visible spectroscopy and in term of antioxidant activity by Electron 
Paramagnetic Resonance spectroscopy (EPR) coupled with spin trapping technique. The NPs were used to 
functionalize cotton and viscose-micromodal fabrics and the transdermal release properties were tested in vitro by 
Franz’s Cell experiment. FNP was proven to be an effective technique to produce tunable size particles. Moreover, 
the nanoencapsulated drug exhibited antioxidant activity. The Franz’s Cell test evidenced a controlled release 
behavior, providing evidence that the bio-functional textile is suitable for applications where sustained release and 
antioxidant properties are required. 
 
Keywords: Antioxidant activity, Bio-functional textiles, Caffeine, Drug delivery, Encapsulation, Flash 
Nanoprecipitation, Hydrophilic, Nanoparticles.   
 
I. INTRODUCTION1 
Nowadays many efforts of pharmaceutical research have been focused on the development of innovative tools and 
approaches to administer drugs in “smart” way i.e. improving therapeutic efficacy while minimizing side effects 
[1]. Among these innovative approaches to drug delivery, the possibility of delivering active substances through 
skin aroused significant interest [2]. In facts skin is the largest tissue of the human body and has significant surface 
area available for drug administration; moreover, it plays the important role of protecting the body from external 
factors, which could significantly reduce side effects during drug administration [3]. Therefore, skin can be used 
as a route of administration for local and systemic drugs; according to Food and Drug Administration the first case 
is defined as topical administration and consists in the application of a drug to a particular area on the outer surface 
of the body, while the latter is defined as transdermal administration and involves the delivery through the dermal 
layer of the skin to the systemic circulation. Despite the numerous advantages in using skin for topical and 
transdermal drug delivery, such administration route is challenging for several compounds because of the structural 
complexity of the skin barrier [4].  Recent developments in nanotechnology and nanomedicine offer several 
approaches to overcome the above mentioned problem [5–8]. In addition, these advanced drug delivery systems 
can be combined with conventional textiles to develop wearable drug delivery devices; this new class of material 
defined as bio-functional textiles has shown the capability to improve the transdermal administration of active 
molecules [9]. Among bio-functional textiles much attention has been gained by transdermal patches that employ 
nano-carrier based drug delivery systems [10]. These patches aim to enhance drug permeation through the skin 
barrier in order to reach the blood circulatory system; such approach allows to obtain a sustained and constant drug 
release in a non-invasive way, while reducing the drug toxicity [11]. Cellulosic substrates and derivatives are the 
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main potential candidates used in this technology, due to their natural biocompatibility, and the absence of side 
effects, such as allergies and skin irritations. Moreover, they are readily available and biodegradable, making them 
a suitable substrate for bio-functional textile preparation [12]. Due to skin barrier complexity only a limited number 
of active compounds with a lipophilic character can penetrate the outer layers of the skin. Thus, the preparation of 
a bio-functional textile usually requires encapsulation of the active substance before functionalizing the textile 
[13], the use of properly designed nanoparticles protects the drug from surrounding agents until it reaches the 
target tissue. Polymeric nanoparticles (NPs) are among the most studied nanocarriers given the large availability 
of polymeric materials that fulfill the requirements of biological applications such as non-toxicity, biodegradability 
and biocompatibility [14]. Furtherly, these carriers have been proved to be effective in entrapping and releasing 
active substances [15], [16]. Poly-ε-caprolactone (PCL) has peculiar features that makes it widely applied in tissue 
engineering, implantable devices, cell cultures and drug delivery [17], [18]. This polymer is commonly 
biodegraded in body fluids by cleavage of the ester bond: the degradation mechanism consists in a first step in 
which the molecular weight decreases due to chain scission and a second one where an actual weight loss is 
observable; the overall process can take several weeks to be completed. Thus this material is suitable for 
applications where long lasting releases are needed [19], and  it has been also successfully employed in transdermal 
applications [20], [21]. Unfortunately, a wide application of such polymeric devices is still a challenging issue due 
to the scarce productivity and scalability of NPs production processes [22], and this issue is even more critical 
dealing with bio-functional textiles given the high amount of NPs that would be required in textile 
functionalization. The Flash Nanoprecipitation technique (FNP) [23] is a suitable process to overcome the above 
mentioned issue given its simplicity, fastness, productivity and good reproducibility of the obtained results [24]. 
FNP exploits the difference of solubility of a polymer in two miscible fluids and partition coefficient in polymer-
solvent system. The polymer is dissolved in an organic solvent which collides against a water jet in a micro reactor 
to generate a highly turbulent mixing, the low affinity of the polymer for the aqueous phase leads to its precipitation 
in the form of nanoparticles [25]. The factor governing the particle formation phenomenon is mainly the mixing 
conditions. Reactors such as the confined impinging jet mixer (CIJM) have been appositively designed in order to 
control the process conditions [26]. On the other hand, the chemical nature of the active substance also influences 
the encapsulation yield. Thus, several studies have shown that the entrapment of hydrophobic substances (LogP 
>3.2) such as curcumin, paclitaxel, menthol and vitamin E can be realized with FNP, while to our knowledge only 
few works deal to encapsulate hydrophilic substances [27]. The aim of this study is to determine the process 
parameters allowing for encapsulating a hydrophilic substance, caffeine (CAF), which represents an opportunity 
for transdermal delivery, due to its potential application in dermatology [28]. CAF is able to protect skin from 
damages caused by UV light, and displays antioxidant activity. Furthermore, it was found that CAF can promote 
the lipolysis at cellular level and act as an anti-cellulite drug [29], [30]. In the present work a FNP methodology is 
proposed to produce CAF loaded PCL nanoparticles. The process parameters as well as the formulations were 
studied in order to achieve NPs of a size similar to the one skin annexes. The tested formulations were characterized 
by measuring their encapsulation efficiency (EE) and loading capacity (LC), while the antioxidant activity of the 
NPs was determined by Electron Paramagnetic Resonance Spectroscopy (EPR) coupled with spin trapping 
technique. The particles were then used to functionalize two different textiles substrates, a cotton and a viscose-
micromodal blend. The release properties of the functionalized textile were tested in vitro in a vertical Franz 
diffusion cell. 
II. MATERIALS AND METHODS 
Materials 
Poly-ε-caprolactone (PCL) (molecular weight of 14000 g/mol), and caffeine (CAF), selected as matrix and active 
substance respectively, were purchased from Sigma Aldrich. Acetone with purity ≥ 99,5% meeting European 
Pharmacopedia standards (Sigma Aldrich) was used as solvent. Phosphate buffer solution used in the release test 
was prepared from sodium chloride anhydrous ≥ 99%, potassium chloride ACS grade ≥ 99,5%, sodium phosphate 
dibasic dehydrate ≥ 99% and potassium dihydrogen phosphate ACS reagent ≥ 99%, also purchased from Sigma 
Aldrich. For the spin trapping reaction 5,5-dimethyl-1-pyrroline N-oxide (DMPO), hydrogen peroxide (30%) and 
iron (II) sulphate were purchased from Sigma Aldrich. Ultrapure water was produced by mean of a Milli-Q RG 
system by Millipore R (Billerica, MA) and employed in all the experimental procedures. Textile materials tested 
were knitted cotton fabrics single jersey made of 100% cotton and a blend of viscose/micromodal 70/30%; they 
were kindly supplied by Eusebio S.p.a (Varese, Italy). 
A. Nanoparticle preparation  
The nanoparticles were prepared by FNP in a CIJM (1 mm inlet tube diameter, 5 mm chamber diameter, 11.2 mm 
chamber height). A stream of polymer organic solvent solution was mixed with an anti-solvent, water (Fig. 1). The 
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collision of the two jets induced polymer precipitation in the form of nanoparticles.  
 
Fig. 1.  Scheme of the FNP employed for the production CAF loaded PCL Nanoparticles. 
 
Defined volumes of acetone solution with the proper concentration of PCL and CAF, and water were placed in 
syringes and fed to the CIJM micro-mixer by a syringe pump (KDS200, KD Scientific, Holliston, MA) at a flow 
rate varying from 20 to 80 ml/min; the concentration of CAF and PCL used in the inlet solutions are shown in 
Table I. Samples of 6 ml (3 ml for each stream) were taken, collected in a glass vial containing 3 ml of quenching 
water placed downstream of the mixer. The collected suspension and the quenching water were kept under 
magnetic stirring for two minutes. The collected nanoparticle suspension was used for further characterizations. 
TABLE I 
FORMULATIONS TESTED. 
Formulation PCL concentration (mg/ml) CAF concentration (mg/ml) 
F1 4.5 9.0 
F2 6.0 9.0 
F3 10.0 7.6 
 
B. Fabrics functionalization 
Fabrics were functionalized by imbibition. The NPs were firstly separated from liquid, in order to obtain about 2 
ml of concentrated NP suspension. 0.5 ml of each suspension were then added dropwise over a disk of textile 
material of about 2 cm in diameter. Particular care was taken to spread the NPs uniformly over the textile surface 
and to let the fabric dry between the drop additions. 
C. Characterizations and analytical methods  
 Particle size analysis 
Particles size distribution was measured by means of DLS Zetasizer Nanoseries ZS90, Malvern Instruments 
(Malvern, UK). Samples were prepared by diluting 0.1 ml of as produced nanoparticles suspensions in 1 ml of 
ultrapure water. All samples were measured in triplicate under controlled temperature at 25.0 ± 0.1 °C. 
 
 Determination of Loading Capacity and Encapsulation Efficiency.  
LC is defined as the mass of encapsulated (men, in g) drug divided by the mass of the whole polymeric nanoparticles 
system (mtot, in g) as given by (1); it is an indicator of the amount of drug that can be incorporated in a given 
amount of nanoparticle formulation. EE is defined as the amount of encapsulated caffeine over its input quantity 
in the process (min, in g) as expressed by (2); it is an index of the efficiency of the nanoparticles production process.
  
(%) =


× 100  (1) 
		(%) =



× 100  (2) 
In order to calculate LC% and EE% a methodology based on the one described in [10] with slight modification 
was employed. Briefly the NPs suspension was placed in a rotary evaporator RE 300 at 50 °C, under vacuum for 
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15 min, to remove acetone; then, it was centrifuged for 30 min at 15800 g in a SL 16 Thermo scientific centrifuge 
in order to separate the liquid from the solid NPs. 0.1 mL supernatant sample was diluted in 25 ml of water and 
analyzed by UV-Vis spectroscopy in a 6850 UV/Vis spectrophotometer, Jenway (Stone, Staffordshire, UK). EE% 
and LC% were calculated indirectly after measuring the amount of unencapsulated caffeine in the supernatant. 
 Antioxidant activity  
The antioxidant activity of nanoparticles was studied by EPR coupled with the spin-trapping technique. For this 
analysis an appositively prepared sample with equal CAF and PCL concentration of F2 but produced by dissolving 
CAF in water was used; the NP was accurately separated from the liquid, taking also care of removing all traces 
of acetone. Hydroxyl radicals were generated in situ by Fenton reaction and trapped using the spin-trap DMPO. 
H2O2 (20 μL, 10mM), DMPO (100 μL, 50 mM) an aqueous solution of nanoparticles at different concentrations 
(78 μL) and FeSO4 (2 μL, 10 mM) were mixed in an Eppendorf tube. The resulting solution was mixed, transferred 
to a quartz microcapillary tube and placed in the EPR cavity for measurement. After 5 minutes since the addition 
of FeSO4, the spectra were recorded on a Bruker EMXnano X-Band spectrometer (Bruker, Billerica, MA, USA). 
The EPR measurements conditions were as follows: Frequency, 9.74 GHz; scan width, 100 G; receiver gain, 60 
dB; time constant, 1.28 ms; sweep time, 80 s; scan, 1. After acquisition, the spectra were processed using the 
Bruker Xenon software (Bruker, Billerica, MA, USA) for baseline correction and the total number of hydroxyl 
radicals trapped was quantified using the SpinFit software (Bruker, Billerica, MA, USA). 
 In vitro release Test  
The release test from the functionalized fabrics was conducted on static vertical Franz diffusion cells (PermeGear, 
Hellertown, PA, USA). The Franz cells were constituted by an upper donor chamber and a lower receptor chamber 
(volume 11.4 mL) with a contact surface of 1.5 cm2. The acceptor compartment was filled with pH 7.4 phosphate 
buffer solution kept at temperature of 33°C by a heating jacket. A cellulose acetate membrane with porosity of 
0.45 µm was used to mimic skin. Prior release test the membrane was boiled in water for 1 h to enhance its 
wettability. 1 ml samples of the acceptor fluid were withdrawn at a fixed time intervals and analyzed for caffeine 
by spectrophotometry; thereafter, an equal volume of the fresh PBS solution was replaced into the cell. 
Experiments were performed in quadruplicate. 
III. RESULTS AND DISCUSSION 
A. Particle size 
To be suitable for a transdermal administration, NPs size should less than the one of skin annexes (approximately 
450 nm). The results of the production of the three formulations at varying inlet flow rate are plotted in Fig. 2.  
 
 
Fig. 2.  Trends in particle diameter at varying flow rate for the different formulation tested.  
 
The particle size tends to decrease as the flow rate is increased. Such result is in accordance with theoretical works 
in which particle formation occurs by two successive steps of nucleation and growth [31]. As a matter of facts, 
increasing solvent and antisolvent flow rate (FR) causes a higher turbulence inside the reactor chamber, which in 
turns increases the number of nuclei formed. This reduces the maximum size reachable by each particle. 
Comparing different formulations, it is noticeable an inverse correlation between the initial PCL concentration and 
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the diameter, this mainly due to greater amount of polymer that can precipitate over the already formed nuclei 
causing the particles to enlarge during the growth stage. 
B. Development of textile treatment 
Given the suitability of the NPs systems for the transdermal release in terms of diameter, the choice of the optimal 
formulation was mainly based on the particle content. In Table II the values of EE and LC for the different 
formulations prepared at FR= 80 ml/min are reported. 
TABLE II 
EE AND LC OF THE DIFFERENT FORMULATIONS AT FR = 80 ML/MIN.  
 
Formulation EE% LC% 
F1 11.3 7.7 
F2 17.4 10.4 
F3 13.1 7.6 
 
The values of the EE below 20% are an expected result given the high affinity of caffeine with water; as previously 
reported FNP is commonly used to encapsulated hydrophobic drug that precipitate together with the polymer due 
to their scarce water solubility. In this study, instead the CAF can be encapsulated only by a mechanical entrapment 
that occurs during the precipitation of the polymer and such phenomenon leads to lower EE values. The F2 displays 
the highest results both in term LC and EE, this mainly due to the good balance between initial caffeine and 
polymer concentration. The low PCL concentration in F1 does limit the available polymer chains for the 
entrapment while the high PCL content in F3 increases the overall mass of the system reducing the LC. Because 
of its capability of incorporating higher amounts of caffeine F2 was chosen as optimal formulation for the textile 
functionalization and release test. The effectiveness of the imbibition protocol was already proved in our previous 
work by SEM analysis [10].  
C. Antioxidant activity 
Hydroxyl radical is a highly reactive chemical species with very short half-life in the order of nanoseconds [32]. 
It is known to be the most biologically active free radical, damaging DNA and initiating lipid peroxidation [33]. 
In this study, the antioxidant activity of CAF loaded nanoparticles in scavenging hydroxyl radicals was studied. 
Hydroxyl radicals were generated using the Fenton reaction (Fe2+ + H2O2 → Fe3+ + OH• + HO-) and the oxidation 
of DMPO spin trap by OH• was studied by EPR [34]. Results are shown in Table III. Addition of empty PCL 
nanoparticles did not significantly protect the spin-trap DMPO from oxidation by Fenton-generated OH• radicals: 
indeed, the acquired DMPO-OH signal intensity did not vary upon the addition of the nanoparticles. On the 
contrary, addition of CAF-loaded PCL nanoparticles protected the spin-trap DMPO from oxidation, markedly 
reducing the spin-adduct DMPO-OH signal. The protective effect is concentration dependent over the range 1 
mg/mL - 4.5 mg/mL CAF-loaded nanoparticles, reaching 49% of DMPO-OH signal decrease for the highest NPs 
concentration. Notably, the corresponding higher amounts of empty PCL nanoparticles displayed negligible OH 
radicals scavenging activity, thus suggesting that the observed hydroxyl radical scavenging ability was only due 
to the CAF loaded in the nanoparticles. Overall, these preliminary data show that the encapsulation of CAF in PCL 
nanoparticles results in a marked hydroxyl radical scavenging ability, thus suggesting PCL-loaded NPs as 
innovative nanoparticle-based antioxidants. 
TABLE III 
OH RADICALS CONCENTRATION NORMALIZED TO THE CONTROL 
 
 
 
 
D. In vitro release test 
The Franz’s Cell experiment aimed to assess the potential of the developed bio-functional textile as a transdermal 
delivery device. The normalized cumulative release curves are plotted in Figure 3, a sample obtained by 
functionalizing the fabric with a solution of free caffeine were used as reference (labeled as CAF COT and CAF 
Water 
(Control) 
Empty NPs  
(4,6 mg/mL) 
CAF-loaded NPs  
(5,75 mg/mL) 
100% 98% 49% 
18th World Textile Conference (AUTEX 2018)
IOP Conf. Series: Materials Science and Engineering 460 (2018) 012044
IOP Publishing
doi:10.1088/1757-899X/460/1/012044
6
 
MIC). The NP used for the release test were formulation F2 produced at a FR of 80 ml/min.  
It is noticeable that two factors play a role in slowing and controlling the release. One is ascribable to the textile 
substrate, as the CAF MIC sample present a slower and release compared to CAF COT, which reaches a plateau 
in less than 2 hours. This fact is mostly due to the smaller diameter of micromodal fibers, which means higher 
surface; this will make the fabric act as a reservoir that controls the diffusion from the fabric toward the membrane. 
Under the same substrate (micromodal), it can be observed that the encapsulation process furtherly slows down 
the release as the kinetics is slower for caffeine-PCL nanoparticles than free caffeine. This is due to a series of 
phenomena occurring: first, the particle must be released from the textile and interact with the membrane, then the 
NP may either pass through the membrane delivering CAF to the acceptor fluid or get stuck in the membrane 
pores; in this case CAF has to diffuse out the NP that may act as a reservoir inside the skin. During the first hour 
the CAF MIC and NP MIC curve present the same slope, and this is due to CAF diffusing out of the particles and 
passing directly through the membrane. 
 
Fig. 3.  Cumulative release curves for textiles functionalized with CAF and NP F2 formulation. 
 
Between 1h and 4h the kinetic of the NP system becomes slower, here the particles get stuck in the membrane and 
CAF is released from the NP facing higher resistance to mass transfer. The overall contribution of those different 
phenomena make the micromodal-NP system the most effective in controlling the drug release. 
IV. CONCLUSION 
The present research inquired the preparation of a bio-functional textile. The employment of the polymeric 
nanoparticles in a transdermal delivery system combined with the proper textile material showed an effective 
control of the drug release kinetics. The use of FNP as a high productivity process was proven suitable even when 
dealing with a hydrophilic drug. The assessment on the antioxidant properties of the NP combined with the 
transdermal release of the textile-NP system provides interesting preliminary results about the possibility of 
administering caffeine through daily worn garments. This could represent an improvement with respect to 
conventional transdermal systems such as creams and ointments that must be locally applied several times a day. 
Once worn next to skin, the fabric can deliver CAF for several hours without any further action of the patient to 
be taken. 
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